Keith R Gollust insider trades: Synta Pharmaceuticals (SNTA) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Keith reports to the SEC
Open-market buys and sales
13 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Dec 14, 2015 | SNTA | ↓ Sell | 600,000 | $0.35 | $208K | By Wyandanch Partners, L.P. | Dec 15, 2015 (1d) |
| Dec 9, 2015 | SNTA | ↓ Sell | 745,892 | $0.38 | $285K | By Wyandanch Partners, L.P. | Dec 9, 2015 (0d) |
| Nov 17, 2015 | SNTA | ↓ Sell | 100,000 | $0.41 | $41K | By Wyandanch Partners, L.P. | Nov 19, 2015 (2d) |
| Nov 10, 2015 | SNTA | ↓ Sell | 188,322 | $0.55 | $103K | By Wyandanch Partners, L.P. | Nov 12, 2015 (2d) |
| Apr 6, 2015 | SNTA | ↑ Buy | 350,000 | $1.75 | $613K | By Wyandanch Partners, L.P. | Apr 8, 2015 (2d) |
| Nov 13, 2013 | SNTA | ↑ Buy | 150,000 | $3.75 | $563K | By Wyandanch Partners, L.P. | Nov 15, 2013 (2d) |
| Jun 29, 2012 | SNTA | ↑ Buy | 150,000 | $5.35 | $802K | By Wyandanch Partners, L.P. | Jul 2, 2012 (3d) |
| Apr 14, 2011 | SNTA | ↑ Buy | 100,000 | $4.89 | $489K | By Wyandanch Partners, L.P. | Apr 18, 2011 (4d) |
| Jan 8, 2010 | SNTA | ↑ Buy | 100,000 | $4.50 | $450K | Direct | Jan 12, 2010 (4d) |
| Aug 13, 2008 | SNTA | ↑ Buy | 116,997 | $7.51 | $878K | By Wyandanch Partners, L.P. | Aug 13, 2008 (0d) |
| May 30, 2008 | SNTA | ↑ Buy | 30,000 | $7.16 | $215K | By Wyandanch Partners, L.P. | Jun 2, 2008 (3d) |
| May 19, 2008 | SNTA | ↑ Buy | 50,000 | $7.05 | $352K | By Wyandanch Partners, L.P. | May 20, 2008 (1d) |
| Feb 9, 2007 | SNTA | ↑ Buy | 180,000 | $10.00 | $1.8M | By Wyandanch Partners, L.P. | Feb 13, 2007 (4d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Keith R Gollust's insider trades
Keith R Gollust is a director at Synta Pharmaceuticals (SNTA). Since Feb 9, 2007, Keith has reported 9 open-market purchases worth $6.2M and 4 sales worth $637K on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (20 filings), option exercises (1 filing), shares returned to the company (1 filing), conversions (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every SNTA insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.